These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 27363225)

  • 21. [Utilization of Multi-Institutional Laboratory Data as an Evidence Database: The Current Status and Future Tasks--Chairmen's Introductory Remarks].
    Miyake K; Nishibori M
    Rinsho Byori; 2015 Jan; 63(1):127-8. PubMed ID: 26524889
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Chair remarks of the symposium. "Updated learning from experts in laboratory disciplines"].
    Miyachi H
    Rinsho Byori; 2013 Nov; 61(11):1052-3. PubMed ID: 24450111
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Team-Based Clinical Laboratory Testing in Nephrology and Urology--Chairmen's Introductory Remarks].
    Hayashi T; Nanri K
    Rinsho Byori; 2014 Nov; 62(11):1094-5. PubMed ID: 27509727
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ["How can hospitals develop a beneficial relationship with laboratory testing companies?" - Chairmen's introductory remarks].
    Morita T; Kawano S
    Rinsho Byori; 2014 Dec; 62(12):1245-6. PubMed ID: 25823241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Case conference of hematological malignancies based on the morphology of blood cells: chairmen's introductory remarks].
    Inaba T; Tohyama K
    Rinsho Byori; 2014 Jul; 62(7):699-701. PubMed ID: 25669040
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [New Guidelines for Hematuria Diagnosis and Future Perspectives on Urinalysis -Chairmen's Introductory Remarks -].
    Inagaki I; Tanaka Y
    Rinsho Byori; 2016 Jun; 64(6):697-698. PubMed ID: 30695327
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Issues Associated with the Management of Clinical Laboratories and Their Future: What is the Problem in Our Laboratory?--Chairmen's Introductory Remarks].
    Morikane K; Kaku M
    Rinsho Byori; 2015 Mar; 63(3):397-9. PubMed ID: 26524864
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The Establishment and Reality of a Quality Management System--Chairmen's Introductory Remarks].
    Shimetani N; Mizuguchi K
    Rinsho Byori; 2015 Jul; 63(7):805-6. PubMed ID: 26591430
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Mass spectrometry application for clinical diagnostics chairmen's introductory remarks].
    Saito K; Nomura F
    Rinsho Byori; 2013 Sep; 61(9):803-4. PubMed ID: 24369592
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Etiology of Secondary Hyperlipidemia and Abnormalities of Lipid Laboratory Tests -Chairmen's Introductory Remarks -].
    Yoshida H; Miida T
    Rinsho Byori; 2016 May; 64(5):506-507. PubMed ID: 30695358
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [How to Interpret and Use Routine Laboratory Data--Our Methods to Interpret Routine Laboratory Data--Chairmen's Introductory Remarks].
    Honda T; Tozuka M
    Rinsho Byori; 2015 Sep; 63(9):1060-3. PubMed ID: 26731894
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [New Horizon in Clinical Examination -Chairmen's Introductory Remarks -].
    Nakatani K; Ishikawa T
    Rinsho Byori; 2016 Oct; 64(10):1154-1155. PubMed ID: 30609473
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Current Status and Future of Lipid Examination in the Prevention and Clinical Treatment of Atherosclerotic Diseases--Chairmen's Introductory Remarks].
    Yoshida H; Miida T
    Rinsho Byori; 2014 Sep; 62(9):876-7. PubMed ID: 27526532
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The Latest Findings in Liver Diseases -Chairman's Introductory Remarks.].
    Ikeda H
    Rinsho Byori; 2016 May; 64(4):463-464. PubMed ID: 29182819
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Laboratory Medicine and Medical Team Approaches--Opening Remarks from the Chair].
    Suwabe A; Yoneyama A
    Rinsho Byori; 2014 Nov; 62(11):1135-6. PubMed ID: 27509735
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Chairmen's introductory remarks].
    Shukuya K; Wada T
    Rinsho Byori; 2013 Jul; 61(7):614-5. PubMed ID: 24205703
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Companion diagnostics in the era of personalized medicine--chairmen's introductory remarks].
    Fukutsuka K; Takubo T
    Rinsho Byori; 2014 Apr; 62(4):378-80. PubMed ID: 25022067
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Measuring hospital-wide activity volume for patient safety and infection control: a multi-centre study in Japan.
    Hayashida K; Imanaka Y; Fukuda H
    BMC Health Serv Res; 2007 Sep; 7():140. PubMed ID: 17764578
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improvements in the safety of patient care can help end the medical malpractice crisis in the United States.
    Dalton GD; Samaropoulos XF; Dalton AC
    Health Policy; 2008 May; 86(2-3):153-62. PubMed ID: 18035446
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Medical technologist as a member of infection control team].
    Okuzumi K; Ieiri T
    Rinsho Byori; 2005 Nov; 53(11):1036-42. PubMed ID: 16372755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.